Search clinical trials for: Pharmacogenomic Study

Total 5623 results

M.D. Anderson Cancer Center

Completed

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

Metastatic Carcinoma in the Adrenal Cortex | Stage III Adrenal Cortex Carcinoma AJCC v8 | Stage IV Adrenal Cortex Carcinoma AJCC v8 | Unresectable Adrenal Cortex Carcinoma

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); Peloton Therapeutics, Inc.

Completed

HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma (PT2385)

Recurrent Glioblastoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Mesenchymal Chondrosarcoma | Dedifferentiated Chondrosarcoma | Unresectable Primary Central Chondrosarcoma | Clear Cell Chondrosarcoma | Locally Advanced Chondrosarcoma | Metastatic Chondrosarcoma | Primary Central Chondrosarcoma

France
National Cancer Institute (NCI)

Terminated

Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia

Recurrent Small Lymphocytic Lymphoma | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia

United States
Medstar Health Research Institute
Kailos Genetics, Inc.

Active, not recruiting

Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care (PGx-ACT)

Chronic Pain

United States
University of Chicago
National Cancer Institute (NCI)

Terminated

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Measuring Effects of Pazopanib Hydrochloride in Patients With Metastatic Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell Cancer

United States
European Organisation for Research and Treatment...

Terminated

Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line Chemotherapy

Lung Cancer

Netherlands, Belgium, United Kingdom, Egypt, France, Germany, Slovenia, Greece
National Cancer Institute (NCI)
Glaxosmithkline Biologicals S.A.

Terminated

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Renal Failure | Solid Neoplasm | BRAF Gene Mutation | Hepatic Complication

United States, Canada
National Cancer Institute (NCI)

Terminated

Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive

United States
National Cancer Institute (NCI)

Terminated

RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery

Stage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
National Cancer Institute (NCI)

Completed

Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies

Unspecified Adult Solid Tumor, Protocol Specific

Canada
Robert Pendleton
University of Louisville

Completed

Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy (PerMIT)

Blood Clotting

United States
National Cancer Institute (NCI)

Active, not recruiting

Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma

Metastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous Melanoma

United States
National Cancer Institute (NCI)

Completed

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck

Stage IV Ovarian Epithelial Cancer | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Ovarian Epithelial Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma... and other conditions

United States
Data Collection Analysis Business Management
PAS Research Services

Unknown

Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

Pharmacogenomic

United States
National Cancer Institute (NCI)

Completed

AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer

United States
Wake Forest University Health Sciences

Terminated

LCI-NOS-PAIN-001: A Prospective, Pharmacogenomic-Driven Study of Pain Management in Oncology Outpatients

Malignant Tumor of Ill-defined Site

United States
Auburn University
Tuscaloosa Veterans Affairs Medical Center

Withdrawn

Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans

Depressive Disorder, Major | Pharmacogenetics | Medication Therapy Management

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

White Button Mushroom Extract in Preventing the Recurrence of Breast Cancer in Postmenopausal Breast Cancer Survivors

Breast Cancer | Cancer Survivor

United States
Tabula Rasa HealthCare

Withdrawn

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

Elderly | Adverse Drug Event | Pharmacogenomics | Drug Drug Interaction

United States
Tabula Rasa HealthCare

Enrolling by invitation

Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting

Polypharmacy | Pharmacogenomics

United States
Mayo Clinic

Completed

Right Drug, Right Dose, Right Time - Using Genomic Data to Individualize Treatment

Healthy Subjects
Mayo Clinic

Completed

Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects

Psychiatric Disorder

United States
Wake Forest University Health Sciences

Completed

Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation (IMPPACT)

Oncology | Hematopoietic Cell Transplantation

United States
Wake Forest University Health Sciences

Completed

Pharmacogenomic Testing to Personalize Supportive Oncology

Depression | Pain | Cancer

United States
Nalagenetics Pte Ltd

Recruiting

Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (PPT Study)

Pre-emptive Pharmacogenomics

Singapore
National Cancer Institute (NCI)

Completed

BMS-247550 in Treating Patients With Stage IV Melanoma

Recurrent Melanoma | Stage IV Melanoma

United States
National Cancer Institute (NCI)

Completed

Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer

United States, Singapore, Australia
Anderson Orthopaedic Research Institute

Unknown

Pharmacogenetics for Pain Management in Joint Replacement Patients (PGx)

Arthroplasty Complications

United States
Clinical and Translational Genome Research Institute...
Children's Specialized Hospital

Terminated

Pharmacogenomics for Improving Pediatric ADHD Treatment

Attention Deficit Disorders With Hyperactivity

United States
Geisinger Clinic

Enrolling by invitation

Preemptive Pharmacogenomics Testing Among Geriatric Patients

Polypharmacy | Pharmacogenomic Testing

United States
National Cancer Institute (NCI)

Completed

Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma

Acute Adult T-Cell Leukemia/Lymphoma | Adult T-Cell Leukemia/Lymphoma | Chronic Adult T-Cell Leukemia/Lymphoma | HTLV-1 Infection | Lymphomatous Adult T-Cell Leukemia/Lymphoma | Smoldering Adult T-Cell Leukemia/Lymphoma

United States
University Hospital, Montpellier

Completed

Study of Tissue Samples From Patients With Glioma or Other Brain Tumors

Central Nervous System Lymphoma

France
Mayo Clinic

Terminated

The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients

Palliative Medicine

United States
National Cancer Institute (NCI)

Active, not recruiting

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm

United States
Avera McKennan Hospital & University Health Center

Completed

Developing an Interdisciplinary Pharmacogenomic Treatment Approach to Reduce Medication Burden and Improve Outcomes

Developmental Disabilities
University of Calgary

Recruiting

Pharmacogenetic Supported Prescribing in Kids (PGx-SParK)

Mental Health Impairment

Canada
Tabula Rasa HealthCare

Enrolling by invitation

Pharmacist-led Pharmacogenomic Clinical Service Within the Program of All-inclusive Care for the Elderly

Pain | Pain, Acute | Elderly | Opioid Use | Pain, Chronic | Pharmacogenetic Testing

United States
Clínica Origen
ANDROFERT - Clinica de Andrologia e Reproducao Humana; Faculdade de Medicina...

Unknown

Pharmacogenetic Algorithm for Individualized Controlled Ovarian Stimulation

Infertility
Avera McKennan Hospital & University Health Center

Completed

Pharmacogenetic Testing in an Outpatient Population of Patients With Depression (PGx-UPA)

Depression

United States
National Cancer Institute (NCI)

Completed

FAU in Treating Patients With Advanced Solid Tumors or Lymphoma

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditions

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma

Lymphoma
Murdoch Childrens Research Institute

Recruiting

Minimising Adverse Drug Reactions and Verifying Economic Legitimacy in Children (MARVEL-PIC) (MARVEL-PIC)

Neoplasms | Bone Marrow Transplantation

Australia
Mayo Clinic

Completed

Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders

Gastrointestinal Diseases

United States
Corporal Michael J. Crescenz VA Medical Center

Recruiting

PRIME Care (PRecision Medicine In MEntal Health Care) 2.0 (PRIME Care 2)

Psychiatric or Mood Diseases or Conditions

United States
University of Michigan

Completed

Pharmacogenomic Testing in Primary Care

Antidepressants Causing Adverse Effects in Therapeutic Use

United States
Columbia University

Terminated

Pharmacogenomic Testing in Major Depressive Disorder

Major Depressive Disorder

United States
Roswell Park Cancer Institute
Bayer

Completed

Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride

Unspecified Adult Solid Tumor, Protocol Specific | Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic Cancer

United States
J.J.Swen
Karolinska Institutet; Medical University of Vienna; Uppsala University; St. Antonius... and other collaborators

Completed

PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions (PREPARE)

Adverse Drug Reaction

Austria, Netherlands, Italy, Greece, Slovenia, Spain, United Kingdom
National Cancer Institute (NCI)

Active, not recruiting

Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery

Recurrent Thyroid Gland Carcinoma | Refractory Thyroid Gland Carcinoma | Stage III Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 | Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 | Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 | Stage... and other conditions

United States

Search clinical trials for: Pharmacogenomic Study

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations